Advertisement

Complement pp 101-114 | Cite as

The Human C3b Receptor

  • Douglas T. Fearon

Abstract

Many of the biologic effects of the complement system are mediated by cellular receptors that specifically bind certain cleavage peptides and larger fragments of complement proteins that are generated during activation of the system. As is discussed elsewhere in this volume and in a recent review [15], there may be as many as eight different complement receptors on the various cell types that participate in immune and inflammatory reactions. A comprehensive understanding of the mechanisms by which the binding of ligands to these receptors evokes cellular responses requires that the membrane proteins serving as receptors be identified,. isolated, and characterized. Recent studies of the first complement receptor to be purified, the human C3b receptor, which is also termed CR1, is the subject of this review.

Keywords

Systemic Lupus Erythematosus Systemic Lupus Erythematosus Patient Complement Receptor Sheep Erythrocyte Structural Polymorphism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abo T, Balch CM (1981) A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 127: 1024PubMedGoogle Scholar
  2. 2.
    Abo T, Cooper MD, Balch CM (1982) Characterization of HNL-1 + (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability. J Immunol 129: 1752PubMedGoogle Scholar
  3. 3.
    Abrahamson DR, Fearon DT (1982) Endocytosis of the C3b receptor of complement within coated pits in human polymorphonuclear leukocytes and monocytes. Lab Invest 48: 162Google Scholar
  4. 4.
    Anderson RGW, Brown MS, Goldstein JL (1977) Role of the coated endocytic vesicle in the uptake of receptor-bound low density lipoprotein in human fibroblasts. Cell 10: 351PubMedCrossRefGoogle Scholar
  5. 5.
    Arnaout MA, Melamed J, Tack BF, Colten HR (1981) Characterization of the human complement (C3b) receptor with a fluid phase C3b dimer. J Immunol 127: 1348PubMedGoogle Scholar
  6. 6.
    Beller DI, Springer TA, Schreiber RD (1982) Anti-Mac-1 selectively inhibits mouse and human type three complement receptor. J Exp Med 156: 1000PubMedCrossRefGoogle Scholar
  7. 7.
    Berger M, Gaither TA, Hammer CH, Frank MM (1981) Lack of binding of human C3, in its native state, to C3b receptors. J Immunol 127: 1329PubMedGoogle Scholar
  8. 8.
    Cornacoff JB, Hebert LA, Smead WL, VanAma ME, Birmingham DJ, Waxman FJ (1983) Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest 71: 236PubMedCrossRefGoogle Scholar
  9. 9.
    Dierich MP, Mussel HH, Scheiner O, Ehlen T, Burger R, Peters H, Schmitt M, Trepke S, Zimmer G (1982) Differentiation of C3b receptors on human lymphocytes, phagocytes, erythrocytes and renal glomerulus cells by monoclonal antibodies. Immunology 45: 85PubMedGoogle Scholar
  10. 10.
    Dobson NJ, Lambris JD, Ross GD (1981) Characteristics of isolated erythrocyte complement receptor type one (CRI, C4–C3b receptor) and CR1-specific antibodies. J Immunol 126: 693PubMedGoogle Scholar
  11. 10a.
    Dykman TR, Cole JL, Iida K, Atkinson JP (1983) Polymorphism of human erythrocyte C3b/C4b receptor. Proc Natl Acad Sci USA 80: 1698PubMedCrossRefGoogle Scholar
  12. 11.
    Fearon DT (1979) Regulation of the amplification C3 concertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc Natl Acad Sci USA 76: 5867PubMedCrossRefGoogle Scholar
  13. 12.
    Fearon DT (1980) Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocytes, B lymphocyte and monocyte. J Exp Med 152: 20PubMedCrossRefGoogle Scholar
  14. 13.
    Fearon DT, Kaneko I, Thomson G (1981) Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes. J Exp Med 153: 1615PubMedCrossRefGoogle Scholar
  15. 14.
    Fearon DT, Collins LA (1983) Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J Immunol 130: 370PubMedGoogle Scholar
  16. 15.
    Fearon DT, Wong WW (1983) Complement ligand-receptor interactions that mediate biological responses. Annu Rev Immunol 1: 243PubMedCrossRefGoogle Scholar
  17. 16.
    Frank MM, Hamburger MI, Lawley TJ, Kimberley RP, Plotz PH (1979) Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 300: 518PubMedCrossRefGoogle Scholar
  18. 17.
    Gelfand MC, Shin ML, Nagle RB, Green I, Frank MM (1976) The glomerular complement receptor in immunologically mediated renal glomerular injury. N Engl J Med 295: 10PubMedCrossRefGoogle Scholar
  19. 18.
    Gerdes J, Naiem M, Mason DY, Stein H (1982) Human complement (C3b) receptors defined by a mouse monoclonal antibody. Immunology 45: 645PubMedGoogle Scholar
  20. 19.
    Gigli I, Nelson RA Jr (1968) Complement dependent immune phagocytosis. Esp Cell Res 51: 45CrossRefGoogle Scholar
  21. 20.
    Glass D, Raum D, Gibson D, Stillman JS, Schur PH (1976) Inherited deficiency of the second component of complement. J Clin Invest 58: 853PubMedCrossRefGoogle Scholar
  22. 21.
    Gordon PO, Carpentier J-L, Cohen S, Orci L (1978) Epidermal growth factor: morphological demonstration of binding, internalization and lysosomal association in human fibroblasts. Proc Natl Acad Sci USA 75: 5025CrossRefGoogle Scholar
  23. 22.
    Hadding U, Hartung HP, Rasokat H, Gemsa G (1983) Peritoneal macrophages release prostaglandin E and thromboxane B2 in response to C3b. In: Normann A, Sarkin E (eds) Macrophages and NK cell function. Plenum Press, New York, in pressGoogle Scholar
  24. 23.
    Hafeman DG, Smith LM, Fearon DT, McConnell HM (1982) Lipid monolayer-coated solid surfaces do not perturb the lateral motion and distribution of C3b receptors on neutrophils. J Cell Biol 94: 224PubMedCrossRefGoogle Scholar
  25. 24.
    Iida K, Nussenzweig V (1981) Complement receptor is an inhibitor of the complement cascade. J Exp Med 153: 1138PubMedCrossRefGoogle Scholar
  26. 25.
    Iida K, Mornaghi R, Nussenzweig V (1982) Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med 155: 1427PubMedCrossRefGoogle Scholar
  27. 26.
    Jack RM, Fearon DT (1983) Cytoskeletal attachment of C3b receptor (C3bR) and reciprocal co-redistribution with Fc receptor (FcR) on human polymorphonuclear leukocytes ( PMN ). Fed Proc 42: 1235Google Scholar
  28. 27.
    Karp DR, Atkinson JP, Schreffler DC (1982) Genetic variation in glycosylation of the fourth component of murine complement: association with hemolytic activity. J Biol Chem 257: 7330PubMedGoogle Scholar
  29. 28.
    Kay AB, Glass EJ, Salter D McG (1979) Leukoattractants enhance complement receptors on human phagocytic cells. Clin Exp Immunol 38: 294Google Scholar
  30. 29.
    Kazatchkine MD, Fearon DT, Appay M-D, Mandet C, Bariety J (1982) Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal disease. J Clin Invest 69: 300CrossRefGoogle Scholar
  31. 30.
    Lambris JD, Cohen PL, Dobson NJ, Wheeler PW, Papamichail M, Ross GD (1982) Effect of antibodies to CR2 ( C3d receptors) on lymphocyte activation. Clin Res 30: 514AGoogle Scholar
  32. 31.
    Lee J, Hakim RM, Fearon DT (1983) Increased expression of C3b receptors on neutrophils induced by complement activation during hemodialysis. Clin Res 31: 492AGoogle Scholar
  33. 32.
    Medicus RG, Arnaout MA (1982) Surface restricted control of C3bINA-dependent C3c release from bound C3bi molecules. Fed Proc 41: 848Google Scholar
  34. 33.
    Medof EM, Prince GM, Mold C (1982) Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of ß1H and is accompanied by release of C3c. Proc Natl Acad Sci USA 79: 5047PubMedCrossRefGoogle Scholar
  35. 34.
    Medof ME, Iidia K, Mold C, Nussenzweig V (1982) Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med 156: 1739PubMedCrossRefGoogle Scholar
  36. 35.
    Melamed J, Arnaout MA, Colten HR (1982) Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release. J Immunol 128: 2313PubMedGoogle Scholar
  37. 36.
    Meuth JL, Morgan EL, Hugli TE (1983) Inhibition of human T cell blastogenesis by a kallikrein cleavage fragment of iC3b. Fed Proc 42: 566Google Scholar
  38. 37.
    Michl J, Pieczonka MM, Unkeless JC, Silverstein SS (1979) Effects of immobilized immune complexes on Fc-and complement-receptor function in resident and thioglycolate-elicited mouse peritoneal macrophages. J Exp Med 150: 607PubMedCrossRefGoogle Scholar
  39. 38.
    Miyakawa Y, Yamada A, Kosaka K, Tsuda F, Kosugi E, Mayumi M (1981) Defective immune adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet 2: 493PubMedCrossRefGoogle Scholar
  40. 39.
    Moran JE, Colasanti G, Amos N, Peters DK (1977) C3b receptors in glomerular disease. Clin Exp Immunol 28: 212PubMedGoogle Scholar
  41. 40.
    Nelson RA (1956) The immune adherence phenomenon: a hypothetical role of erythrocytes in defense against bacteria and viruses. Proc R Soc Exp Biol Med 49: 55Google Scholar
  42. 41.
    Newman SL, Musson RA, Henson PM (1980) Development of functional complement receptors during in vivo maturation of human monocytes into macrophages. J Immunol 125: 2236PubMedGoogle Scholar
  43. 42.
    Ortaldo JR, Sharrow O, Timonen T, Herberman RB (1981) Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J Immunol 127: 2401PubMedGoogle Scholar
  44. 43.
    Perlmann HP, Perlmann RD, Schreiber RD, Muller-Eberhard HJ (1981) Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors: enhancement of antibody-mediated cellular cytotoxicity. J Exp Med 153: 1592PubMedCrossRefGoogle Scholar
  45. 44.
    Petty HR, Smith LM, Fearon DT, McConnell HM (1980) Lateral distribution and diffusion of the C3b receptor of complement, HLA antigens, and lipid probes in peripheral blood leukocytes. Proc Natl Acad Sci USA 77: 6587PubMedCrossRefGoogle Scholar
  46. 45.
    Raum D, Awdeh Z, Yunis EJ, Alper CA (1981) Major histocompatibility markers in disease. Clin Immunol Allergy 1: 305Google Scholar
  47. 46.
    Ross GD, Rabellino EM, Polley MJ, Grey HM (1973) Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. J Clin Invest 52: 377PubMedCrossRefGoogle Scholar
  48. 47.
    Ross GD, Winchester RJ, Rabellino EM, Hoffman T (1978) Surface markers of complement receptor lymphocytes. J Clin Invest 62: 1086PubMedCrossRefGoogle Scholar
  49. 48.
    Ross GD, Lambris JD, Cain JA, Newman SL (1982) Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H versus CR1 cofactor activity. J Immunol 129: 2051PubMedGoogle Scholar
  50. 49.
    Sim E, Sim RB (1983) Enzymatic assay of C3b receptor on intact cells and solubilized cells. Biochem J, in pressGoogle Scholar
  51. 50.
    Sobel AT, Gabay YE, Lagrue G (1976) Analysis of glomerular complement receptors in various types of glomerulonephritis. Clin Immunol Immunopathol 6: 94PubMedCrossRefGoogle Scholar
  52. 51.
    Tedder TF, Fearon DT, Gartland GL, Cooper MD (1983) Expression of C3b receptors on human B cells and myelomonocytic cells but not natural killer cells. J Immunol 130: 1668PubMedGoogle Scholar
  53. 52.
    Timonen T, Ortaldo JR, Herberman RB (1981) Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 153: 569PubMedCrossRefGoogle Scholar
  54. 53.
    Van de Griend RJ, Berge IT, Tanke HJ, Roos D, Schellekens PTA, Melief CJM, Zeijlemaker WP, Astaldi A (1982) Characterization of two subsets of human T cells. J Immunol 128: 1979PubMedGoogle Scholar
  55. 54.
    Willingham MC, Maxfield FR, Pastan IH (1979) Macroglobulin binding to the plasma membrane of cultured fibroblasts: diffuse binding followed by clustering in coated regions. J Cell Biol 82: 614PubMedCrossRefGoogle Scholar
  56. 55.
    Wilson JG, Wong WW, Schur PH, Fearon DT (1982) Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med 307: 981PubMedCrossRefGoogle Scholar
  57. 56.
    Wilson JG, Tedder TF, Fearon DT (1983) Characterization of human T lymphocytes that express the C3b receptor. J Immunol, in pressGoogle Scholar
  58. 57.
    Wong W, Wilson J, Fearon DT (1983) Genetic regulation of a structural polymorphism of human C3b receptor. J Clin Invest, in pressGoogle Scholar
  59. 58.
    Wright SD, Silverstein SC (1982) Tumor-promoting phorbol esters stimulate C3b and C3b’ receptor-mediated phagocytosis in cultured human monocytes. J Exp Med 156: 1149PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • Douglas T. Fearon
    • 1
  1. 1.Department of Medicine, Harvard Medical School, and Department of Rheumatology and ImmunologyBrigham and Women’s HospitalBostonUSA

Personalised recommendations